Effect of a Dose-Escalation Regimen for Improving Adherence to Roflumilast in Patients with Chronic Obstructive Pulmonary Disease

BACKGROUND: The adverse effects of the phosphodiesterase-4 inhibitor roflumilast, appear to be more frequent in clinical practice than what was observed in chronic obstructive pulmonary disease (COPD) clinical trials. Thus, we designed this study to determine whether adverse effects could be reduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Hyunjung, Shin, Ji Young, Park, Kyu Ree, Shin, Jae Ouk, Song, Kyoung-hwan, Park, Joonhyung, Park, Jeong Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620324/
https://www.ncbi.nlm.nih.gov/pubmed/26508918
http://dx.doi.org/10.4046/trd.2015.78.4.321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620324/
https://www.ncbi.nlm.nih.gov/pubmed/26508918
http://dx.doi.org/10.4046/trd.2015.78.4.321

Ejemplares similares